Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer

Cannabidiol, a major non-psychotomimetic compound derived from Cannabis sativa, is a potential therapeutic agent for a variety of diseases such as inflammatory diseases, chronic neurodegenerative diseases, and cancers. Here, we found that the combination of cannabidiol and TNF-related apoptosis-indu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Autores principales: Kim, Jung Lim, Kim, Bo Ram, Kim, Dae Yeong, Jeong, Yoon A., Jeong, Soyeon, Na, Yoo Jin, Park, Seong Hye, Yun, Hye Kyeong, Jo, Min Jee, Kim, Bu Gyeom, Kim, Han Do, Kim, Dae Hyun, Oh, Sang Cheul, Lee, Sun Il, Lee, Dae-Hee
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562873/
https://ncbi.nlm.nih.gov/pubmed/31075907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050642
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares